Neutralization of Knops system antibodies using soluble complement receptor 1

Transfusion

Volumn 36, Issue 6, 1996, Pages 517-520

  Moulds, J M ^a   Rowe, K E ^b,c  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b Gulf Coast Regional Blood Center   (United States)

^c Lawrence and Memorial Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIBODY; BLOOD GROUP ANTIBODY; BLOOD GROUP ANTIGEN; COMPLEMENT RECEPTOR; NEUTRALIZING ANTIBODY;

ANTIBODY DETECTION; ANTIBODY TITER; ANTIGEN EXPRESSION; ARTICLE; BLOOD GROUP LEWIS SYSTEM; BLOOD GROUP TYPING; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN;

EID: 0030017606     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.1996.36696269510.x     Document Type: Article

References (14)

1. Obarski G, Edwards-Moulds JM. A protocol for the use of Lewis-neutralized serum in prenatal antibody screening. J Med Tech 1984;1:377-80.
2. Crookston MC. Soluble antigens and leukocyte related antibodies. Part A. Blood group antigens in plasma: an aid in the identification of antibodies. In: Dawson RD, ed. Transfusion with "crossmatch compatible" blood. Washington: American Association of Blood Banks, 1975;20-5.
3. Middleton J, Crookston MC. Chido-substance in plasma. Vox Sang 1972;23:256-61.
4. Giles CM, Batchelor JR, Dodi IA, et al. C4 and HLA haplotypes associated with partial inhibition of anti-Rg and anti-Ch. J Immunogenet 1984;11:305-17.
5. a (Cost). Vox Sang 1975;29:145-53.
6. a), a high-frequency erythrocyte antigen. Transfusion 1970;10:137-8.
7. a(Knops). Transfusion 1978;18:566-8.
8. Moulds JM, Nickells MW, Moulds JJ, et al. The C3b/C4b receptor is recognized by the Knops, McCoy, Swain-langley, and York blood group antisera. J Exp Med 1991;173:1159-63.
9. Rao N, Ferguson DJ, Lee SF, Telen MJ. Identification of human erythrocyte blood group antigens on the C3b/C4b receptor. J Immunol 1991;146:3502-7.
10. Weisman HF, Bartow T, Leppo MK, et al. Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis. Science 1990;249:146-51.
11. Moulds JM, Moulds JJ, Brown M, Atkinson JP. Antiglobulin testing for CR1-related (Knops/McCoy/Swain-Langley/York) blood group antigens: negative and weak reactions are caused by variable expression of CR1. Vox Sang 1992;62:230-5.
12. Walker RH, ed. Technical manual. 11th ed. Bethesda: American Association of Blood Banks, 1993.
13. Wilson JG, Murphy EE, Wong WW, et al. Identification of a restriction fragment length polymorphism by a CR1 cDNA that correlates with the number of CRI on erythrocytes. J Exp Med 1986;164:50-9.
14. Yoon SH, Fearon DT. Characterization of a soluble form of the C3b/C4b receptor (CRI) in human plasma. J Immunol 1985;134:3332-8.